一类强效抗疟药物及其在感染的红细胞中的特定积累
Kai Wengelnik1, Valerie Vidal, Marie L Ancelin
1CNRS UMR 5539, CP 107, CNRS UMR 5810, CP 22, Université Montpellier II, Place E. Bataillon, 34095 Montpellier Cedex 5, France.
针对酸胆生物合成的新型抗疟疾药物显示出强烈的疗效. 化合物G25有效地抑制疟疾寄生虫的生长,具有低毒性,提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 寄生虫学的寄生虫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 疟疾寄生虫在红细胞内的无性发育过程中广泛合成膜脂质.
- 这种脂质合成是一种潜在的药物点,因为它不在成熟的红细胞中.
研究的目的:
- 识别和评估抑制新型固醇胆生物合成的化合物作为潜在的抗疟疾药物.
- 评估化合物G25对疟疾寄生虫的疗效和毒性.
主要方法:
- 选抑制酸丁胆生物合成的化合物.
- 在实验室中使用Plasmodium falciparum和Plasmodium vivax进行生长抑制测定.
- 哺乳动物细胞系毒性测定.
- 在感染非人类灵长类动物的体内疗效研究.
主要成果:
- 抑制类胆生物合成的化合物显示出强大的抗疟疾活性.
- 化合物G25在实验室中强烈抑制了P. falciparum和P. vivax的生长.
- 与其抗疟疾功效相比,G25对哺乳动物细胞的毒性明显较低 (1000倍的差异).
- 一种放射性标记的G25衍生物选择性地积聚在感染的红细胞中.
- 低剂量G25治疗完全治愈了感染子的疟疾.
结论:
- 抑制de novo酸丁胆生物合成是开发抗疟疾药物的可行策略.
- 由于其强大的疗效,选择性和体内活性,G25是一种非常有前途的抗疟疾候选药物.
更多相关视频
08:01Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
相关概念视频
Cell-mediated Immune Responses
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Vaccines
